Judge Farnan recently construed the claim terms in a patent related to a combination of “(1) the (-) -enantiomer of an antiviral agent known as BCH-189…and (2) the well-known HIV antiviral agent AZT.” Glaxo Group Ltd. v. Teva Pharmaceuticals USA, Inc., C.A. No. 07-713-JJF, Memo. Order (D. Del. Apr. 30, 2009). The following claim terms were construed:
– “method for the treatment of a mammal including man, suffering from or susceptible to infection by HIV” (the Court found no construction necessary)
– “form of dosage unit”
– “pharmaceutically acceptable carrier”
The parties also submitted the terms “comprises” and “includes” for construction. The Court chose to adopt a standard jury instruction either prepared by the AIPLA or one agreed upon by the parties as to the meaning of those terms. Id. at 3-4.